Sabra Healthcare REIT (NASDAQ:SBRA) Releases Quarterly Earnings Results, Misses Estimates By $0.27 EPS

Sabra Healthcare REIT (NASDAQ:SBRA) issued its quarterly earnings data on Monday. The real estate investment trust reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.27), FiscalAI reports. Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.33%. The firm had revenue of $230.11 million during the quarter, compared to analyst estimates of $219.39 million. During the same period in the previous year, the firm posted $0.38 earnings per share. The company’s quarterly revenue was up 24.7% compared to the same quarter last year.

Sabra Healthcare REIT Trading Up 0.9%

SBRA traded up $0.19 on Wednesday, reaching $20.85. 738,453 shares of the company’s stock were exchanged, compared to its average volume of 2,794,661. The company’s 50 day moving average is $19.77 and its 200-day moving average is $19.94. Sabra Healthcare REIT has a twelve month low of $17.17 and a twelve month high of $22.77. The company has a debt-to-equity ratio of 0.96, a quick ratio of 4.72 and a current ratio of 4.72. The company has a market cap of $5.26 billion, a price-to-earnings ratio of 33.10, a PEG ratio of 1.59 and a beta of 0.64.

Sabra Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, August 31st. Stockholders of record on Friday, August 14th will be issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 5.8%. The ex-dividend date is Friday, August 14th. Sabra Healthcare REIT’s dividend payout ratio is presently 190.48%.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. Barclays initiated coverage on Sabra Healthcare REIT in a research report on Tuesday, July 7th. They issued an “overweight” rating and a $21.00 target price for the company. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, July 22nd. Truist Financial lifted their target price on Sabra Healthcare REIT from $22.00 to $24.00 and gave the company a “buy” rating in a report on Wednesday, July 22nd. Citigroup reissued a “market outperform” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Finally, Wells Fargo & Company boosted their price objective on Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock an “overweight” rating in a research report on Monday, June 1st. Eight equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $22.25.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the stock. Smartleaf Asset Management LLC raised its position in shares of Sabra Healthcare REIT by 97.7% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock valued at $27,000 after acquiring an additional 714 shares in the last quarter. Danske Bank A S bought a new position in Sabra Healthcare REIT in the third quarter worth about $30,000. Larson Financial Group LLC boosted its stake in Sabra Healthcare REIT by 42.3% in the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock valued at $35,000 after acquiring an additional 553 shares during the period. EverSource Wealth Advisors LLC boosted its stake in Sabra Healthcare REIT by 150.7% in the second quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock valued at $47,000 after acquiring an additional 1,536 shares during the period. Finally, Quarry LP bought a new position in shares of Sabra Healthcare REIT during the third quarter valued at approximately $48,000. 99.40% of the stock is owned by institutional investors and hedge funds.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.